AI summary Trust: medium Third-party lab

Janoshik tested this tirzepatide at 99.861% purity via HPLC. The tested quantity of 45.66mg showed a significant 14.15% deviation from the 40mg label. Endotoxin status is unknown, but the test is recent (3-6 months old). Customers can cross-check on the lab's public verification URL.

Watch out for
  • no endotoxin test
  • quantity deviation (14%+)
Test date
2025-12-09
Purity
99.86% 99.861%
Batch / lot
—
Lab
Janoshik
Quantity
label 40mg tested 45.66mg
Qty vs label
+14.2%
Endotoxins
—
Test score
—
Manufacturer
Kerui Peptide HongKong Co., Ltd
View vendor profile
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Janoshik (public)

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC
Dose
40mg
Catalogued
2026-04-22
Artifact hash
9b8219d95d03e796…
OCR text

Raw extracted text

Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display. 

{"peptide": "Tirzepatide", "dose": "40mg", "purity_pct": 99.861, "purity_label": "99.861%", "method": "HPLC", "test_date": "2025-12-09", "client": "[EMAIL_REDACTED]", "notes": "", "label_qty": "40mg", "tested_qty": "45.66mg", "quantity_deviation_pct": 14.15, "is_blend": false, "components_json": "", "ocr_confidence": 0.95}
This COA is part of TitrateLab's community-trust corpus. See more from Kerui Peptide HongKong Co., Ltd or learn how trust scores are computed on the methodology page. New to lab reports? How to read a COA →